Economiic Home Method Watch Market RSI Search

Instil Bio, Inc. TIL

Sector:

Healthcare

Industry:

Biotechnology

Description:

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
Instil Bio, Inc. website

Recent Quarter:

2024-11-13

Upcoming Quarter:

2025-03-20

Annual Reports

Date2024-03-21
Revenue 0
Net Income -156,087,000
EPS -24
Basic Shares 6,503,913
Diluted Shares 6,503,913
Report Link
Date2023-03-31
Revenue 0
Net Income -223,177,000
EPS -34.46
Basic Shares 6,475,630
Diluted Shares 6,475,630
Report Link
Date2022-03-07
Revenue 0
Net Income -156,794,000
EPS -24.3
Basic Shares 6,451,413
Diluted Shares 6,451,413
Report Link
Date2020-12-31
Revenue 138,000
Net Income -37,738,000
EPS -5.89
Basic Shares 6,410,612
Diluted Shares 6,410,612
Report Link
Date2019-12-31
Revenue 0
Net Income -6,454,000
EPS -1.01
Basic Shares 6,410,612
Diluted Shares 6,410,612
Report Link

Annual Ratios

Date2023-12-31
PE -0.32
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -0.37
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -14.08
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -89.83
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -525.25
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-13
Revenue 0
Net Income -23,021,000
EPS -3.54
Basic Shares 6,506,681
Diluted Shares 6,506,681
Report Link
Date2024-08-13
Revenue 0
Net Income -14,917,000
EPS -2.29
Basic Shares 6,503,913
Diluted Shares 6,503,913
Report Link
Date2024-05-10
Revenue 0
Net Income -24,302,000
EPS -3.74
Basic Shares 6,503,913
Diluted Shares 6,503,913
Report Link
Date2024-03-21
Revenue 7,670,000
Net Income -12,925,000
EPS -1.99
Basic Shares 6,503,913
Diluted Shares 6,503,913
Report Link
Date2023-11-13
Revenue 0
Net Income -67,432,000
EPS -10.37
Basic Shares 6,503,954
Diluted Shares 6,503,954
Report Link
Date2023-08-14
Revenue 0
Net Income -18,662,000
EPS -2.87
Basic Shares 6,503,954
Diluted Shares 6,503,954
Report Link
Date2023-05-11
Revenue 0
Net Income -56,326,000
EPS -8.66
Basic Shares 6,503,954
Diluted Shares 6,503,954
Report Link
Date2023-03-31
Revenue 0
Net Income -53,844,000
EPS -8.29
Basic Shares 6,493,640
Diluted Shares 6,493,640
Report Link
Date2022-11-14
Revenue 0
Net Income -56,224,000
EPS -0.43
Basic Shares 129,680,217
Diluted Shares 129,680,217
Report Link
Date2022-08-12
Revenue 0
Net Income -58,992,000
EPS -0.46
Basic Shares 129,367,833
Diluted Shares 129,367,833
Report Link
Date2022-05-16
Revenue 0
Net Income -54,117,000
EPS -0.42
Basic Shares 129,119,462
Diluted Shares 129,119,462
Report Link
Date2022-03-07
Revenue 0
Net Income -55,350,000
EPS -0.43
Basic Shares 128,952,362
Diluted Shares 128,952,362
Report Link
Date2021-11-15
Revenue 0
Net Income -43,005,000
EPS -0.33
Basic Shares 128,794,142
Diluted Shares 128,794,142
Report Link
Date2021-08-12
Revenue 0
Net Income -35,311,000
EPS -0.27
Basic Shares 128,743,123
Diluted Shares 128,743,123
Report Link
Date2021-05-13
Revenue 0
Net Income -23,128,000
EPS -0.66
Basic Shares 34,976,652
Diluted Shares 34,976,652
Report Link
Date2020-12-31
Revenue 0
Net Income -17,185,000
EPS -0.49
Basic Shares 34,976,652
Diluted Shares 34,976,652
Report Link
Date2020-09-30
Revenue 52,000
Net Income -7,262,000
EPS -0.12
Basic Shares 61,937,126
Diluted Shares 61,937,126
Report Link
Date2020-06-30
Revenue 42,000
Net Income -9,202,000
EPS -0.15
Basic Shares 61,937,126
Diluted Shares 61,937,126
Report Link
Date2020-03-31
Revenue 44,000
Net Income -4,089,000
EPS -0.066
Basic Shares 61,937,126
Diluted Shares 61,937,126
Report Link

Quarterly Ratios

Date2024-09-30
PE -4.76
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -1.12
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -0.71
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -0.96
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -0.21
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -0.96
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -0.38
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -0.38
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -55.82
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -50.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -128.24
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -199.31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -267.67
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -352.20
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -189.64
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -269.07
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -1127.53
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -889.82
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -2002.47
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

25.69

Price:

$23.36

Market Cap:

152,444,790

EPS TTM:

-11.56

PE Ratio:

-2.02

PEPSG:

2.2190

Fwd PE:

-4.49

Volume:

301,482

2 Year Price Change

0.735

Index 2 Year Price Change

1.497

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: